ArticleHuman mutation2026

Integrative Systems Biology and Experimental Validation Unveil GALNT14 as a Novel Diagnostic Biomarker and Therapeutic Target for Sepsis.

Xiuqi Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.